Cardinal Health (NYSE:CAH) has been assigned a $72.00 price target by stock analysts at Jefferies Group in a research report issued to clients and investors on Friday. The firm presently has a “hold” rating on the stock. Jefferies Group’s price target points to a potential upside of 7.91% from the stock’s current price.
Several other equities analysts have also commented on CAH. Needham & Company LLC reiterated a “hold” rating on shares of Cardinal Health in a research report on Thursday, October 12th. Mizuho set a $70.00 price objective on shares of Cardinal Health and gave the company a “hold” rating in a research report on Tuesday, October 24th. Zacks Investment Research upgraded shares of Cardinal Health from a “sell” rating to a “hold” rating in a research report on Wednesday, November 8th. Argus lowered shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Wednesday, November 15th. Finally, Morgan Stanley lowered shares of Cardinal Health from an “equal weight” rating to an “underweight” rating in a research report on Monday, November 20th. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have given a buy rating to the stock. Cardinal Health presently has an average rating of “Hold” and an average price target of $75.84.
Cardinal Health (CAH) traded up $0.09 on Friday, reaching $66.72. 4,350,000 shares of the company traded hands, compared to its average volume of 3,180,000. The stock has a market capitalization of $21,020.00, a PE ratio of 11.60, a price-to-earnings-growth ratio of 1.45 and a beta of 0.95. Cardinal Health has a 52 week low of $54.66 and a 52 week high of $84.88. The company has a quick ratio of 0.52, a current ratio of 1.09 and a debt-to-equity ratio of 1.19.
Cardinal Health announced that its board has initiated a stock buyback program on Thursday, February 8th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s management believes its shares are undervalued.
In other news, CEO Michael C. Kaufmann sold 18,586 shares of the firm’s stock in a transaction dated Monday, January 22nd. The shares were sold at an average price of $73.90, for a total value of $1,373,505.40. Following the completion of the sale, the chief executive officer now owns 211,849 shares in the company, valued at approximately $15,655,641.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.97% of the stock is currently owned by company insiders.
Several institutional investors have recently added to or reduced their stakes in the company. Farmers National Bank lifted its holdings in shares of Cardinal Health by 1.9% in the 2nd quarter. Farmers National Bank now owns 4,902 shares of the company’s stock worth $382,000 after acquiring an additional 90 shares during the last quarter. Advisory Services Network LLC lifted its holdings in Cardinal Health by 18.4% during the 2nd quarter. Advisory Services Network LLC now owns 1,739 shares of the company’s stock valued at $136,000 after buying an additional 270 shares in the last quarter. Ameritas Investment Partners Inc. lifted its holdings in Cardinal Health by 2.3% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 15,232 shares of the company’s stock valued at $1,185,000 after buying an additional 345 shares in the last quarter. Colony Group LLC lifted its holdings in Cardinal Health by 2.0% during the 2nd quarter. Colony Group LLC now owns 19,571 shares of the company’s stock valued at $1,525,000 after buying an additional 388 shares in the last quarter. Finally, Scotia Capital Inc. lifted its holdings in Cardinal Health by 12.5% during the 2nd quarter. Scotia Capital Inc. now owns 4,108 shares of the company’s stock valued at $320,000 after buying an additional 456 shares in the last quarter. Hedge funds and other institutional investors own 88.00% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Jefferies Group Reiterates $72.00 Price Target for Cardinal Health (CAH)” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2018/02/10/jefferies-group-reiterates-72-00-price-target-for-cardinal-health-cah.html.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.